Hologic logo

    Company profile

    Hologic

    Profiled by the AIDE Institute

    Hologic (HOLX) has an AIDE Index (Sector), 2026 score of 46.88 out of 100, placing it #32 of 59 companies in the Health Care sector. Its Matrix Quadrant (Sector) is Health Care Stealth Adopters. The AIDE Index measures observable AI adoption through public evidence, scored against sector peers.

    Edition
    AIDE Index 2026 · S&P 500, 2026-Q2 · Previous edition
    Matrix Quadrant (Sector)
    Stealth Adopter
    Health Care sector position
    #32
    of 59 Health Care peers
    AIDE Index (Sector), 2026
    AIDE Index (Sector), 2026: 46.88 / 100

    Where does Hologic sit among Health Care peers?

    Matrix Quadrant (Sector), AIDE Index 2026: Health Care Stealth Adopters

    Horizontal axis: Strategic Intent. Vertical axis: Operational Integration. Each divider is the median of the same GICS sector in the same edition.

    • Stealth Adopters

      Lower Strategic Intent, higher Operational Integration

      This company’s category

      • Hologic logo
    • AI Trailblazers

      Higher Strategic Intent, higher Operational Integration

    • Emerging Adopters

      Lower Strategic Intent, lower Operational Integration

      • Molina Healthcare logo
    • AI Visionaries

      Higher Strategic Intent, lower Operational Integration

    Quadrants are assigned against the median of the same GICS sector in the same edition. Exact axis values and positions within a quadrant are not public.

    How the AIDE Matrix works

    Ticker
    HOLX
    GICS sector
    Health Care
    Industry
    Health Care Equipment
    1. Step 1

      Compare with a competitor

      Comparisons are available only for AIDE Index 2.0 companies in the same sector.

    2. Step 2

      Share your score

      Share this profile

      Post on LinkedIn (opens in a new tab)Email

    3. Step 3

      Want more?

      License AIDE data for the full peer set, pillar evidence and documented use cases.

      Request the full analysis

    Official company websitehologic.com

    Documented from public evidence

    How is Hologic using AI?

    A small, selected preview of AI use by Hologic that the AIDE Institute has documented from public sources such as filings, earnings calls and company announcements. It is not the complete set.

    Enter your email to access more information

    AIDE Index 2026 · S&P 500, 2026-Q2 · Previous edition

    What does the AIDE Index show for Hologic?

    This is a sector-relative signal for AIDE Index 2026, not a full organizational benchmark.

    Enter your email to access more information

    Editions

    How do the published editions compare for Hologic?

    Enter your email to access more information

    Quick answers about Hologic

    What is Hologic’s AIDE Index (Sector), 2026 score?

    Hologic has an AIDE Index (Sector), 2026 score of 46.88 out of 100. The score is sector-relative: it compares Hologic only with other Health Care companies.

    Where does Hologic place in Health Care?

    Hologic places #32 of 59 Health Care companies on AIDE Index (Sector), 2026. #1 is the highest score in the sector.

    What is Hologic’s Matrix Quadrant (Sector)?

    Hologic’s Matrix Quadrant (Sector) is Health Care Stealth Adopters. The quadrant is assigned within the Health Care sector, not across all sectors.

    What do the four pillars show?

    Literacy reflects what leaders know, Advocacy what leaders say, Orientation what the organization prioritizes and Implementation what the organization builds. Each pillar (Sector) is scored from 0 to 100 against the same sector peer group. See the AIDE Index methodology.

    About this profile

    This public profile is a snapshot of the AIDE Index (Sector), 2026 result for Hologic: its score and position among Health Care companies, its four pillars and its Matrix Quadrant (Sector), measured from public evidence rather than surveys. The use-case summaries are a small, selected preview of documented AI use.

    It shows where Hologic stands within its sector on the public record. Deeper interpretation, sector context and the source-linked evidence behind each result are part of AIDE’s full analysis, available by request.

    Definitions

    AIDE Index (Sector), 2026
    A 0 to 100 measure of observable AI adoption built from public evidence and scored against companies in the same GICS sector and edition. It does not establish financial returns or capture every internal AI initiative. See the AIDE Index methodology.
    Sector position
    Where the company places among Health Care companies on AIDE Index (Sector). #1 is the highest score in the sector.
    Matrix Quadrant (Sector)
    One of the four AI-Driven Enterprise Matrix quadrants, assigned within the sector. See how the AIDE Matrix works.
    Pillars (Sector)
    Literacy, Advocacy, Orientation and Implementation, each scored from 0 to 100 against the same sector peer group.

    Full company analysis

    What does the public evidence mean for Hologic?

    Get the complete detected use-case portfolio, source-linked evidence, deployment context, competitor patterns and expert interpretation from AIDE’s enterprise AI research team.

    AIDE’s research leadership includes Paul Cheek, CEO and Co-Founder of AIDE and Senior Lecturer at MIT Sloan, alongside researchers and practitioners with experience in AI, strategy and enterprise transformation.

    More Health Care company profiles

    Companies placed near Hologic on AIDE Index (Sector), 2026.

    Beyond the public profile

    What does the public evidence mean for Hologic?

    The public profile shows the approved signals. A full AIDE analysis examines the source record behind them and explains what the pattern means for Hologic in its Health Care context. The work is built from public, verifiable evidence by a specialist research team focused on enterprise AI adoption.

    The analysis connects leadership, strategy, talent and deployed AI to the complete set of detected use cases, cited sources, deployment stages and reported outcomes. Company-reported claims remain clearly identified as claims.

    The full analysis is designed to:

    1. Distinguish stated AI ambition from observable execution.
    2. Explain how the four AIDE pillars combine within the correct sector context.
    3. Review the complete set of detected use cases and the evidence attached to each one.
    4. Surface evidence gaps, contradictions and unanswered questions that deserve follow-up.
    5. Produce a cited briefing for strategy, diligence and board-level discussion.

    AIDE’s research leadership includes Paul Cheek, CEO and Co-Founder of AIDE and Senior Lecturer at MIT Sloan, alongside researchers and practitioners with experience in AI, strategy and enterprise transformation.

    Request full analysis accessRequest another company